A phase II clinical trial of carbon-ion radiotherapy using 4 fractions for hepatocellular carcinoma greater than 30mm
Not Applicable
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000013538
- Lead Sponsor
- SAGA HIMAT foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient have recieved any other therapies for hepatocellular carcinoma. 2) The alimentary tract is included in the planning target volume. 3) Patient with ascites. 4) Patient with hepatic encephalopathy. 5) Patient with sever paraesophageal varix or portal hypertention. 6) Patient with intractable esophageal or gastric varix. 7) Patients with any other active malignancies. 8) Patients with active and intractable infection at the same position where carbon-ion radiotherapy is planned.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year overall survival 3-year cause-specific survival
- Secondary Outcome Measures
Name Time Method 3-year local control rate Normal tissue reaction